The Journal of Practical Medicine >

2025 , Vol. 41 >Issue 22: 3474 - 3479

DOI: https://doi.org/10.3969/j.issn.1006-5725.2025.22.002

Feature Reports：Reproductive Health

Clinical outcomes of three treatment protocols for frozen⁃thawed embryo transfer in patients with thin endometrium

  • Congshun MA ,
  • Yuanyuan CUI ,
  • Wanshan ZHU ,
  • Xuejun ZHAN ,
  • Ying TAN
Expand
  • NHC Key Laboratory of Male Reproduction and Genetics；Department of Reproductive Medicine Center，Guangdong Provincial Reproductive Science Institute （Guangdong Provincial Fertility Hospital），Guangzhou 510600，Guangdong，China

Received date: 2025-08-11

  Online published: 2025-11-26

Fold

Abstract

Objective To compare the clinical pregnancy outcomes of tamoxifen （TAM） ， TAM combined with intrauterine perfusion of platelet-rich plasma （PRP）， and hormone replacement therapy （HRT） combined with intrauterine perfusion of PRP for frozen-thawed embryo transfer （FET） in patients with thin endometrium. Methods A retrospective analysis was performed on clinical data of 321 patients with thin endometrium （endometrial thickness ≤ 7 mm in previous cycles） who underwent FET at the Reproductive Medicine Center of Guangdong Provincial Reproductive Hospital from January 2023 to April 2025. According to the treatment protocols，the patients were divided into three groups： TAM group （Group A， n = 98）， TAM + PRP group （Group B， n = 91）， and HRT + PRP group （Group C， n = 132）. General information， endometrial thickness on the conversion day before and after treatment， clinical pregnancy outcomes， andcosts of endometrial preparation treatment were compared among the three groups. Results There were no significant differences in age， duration of infertility， type of infertility， anti-Müllerian hormone （AMH） level， basal follicle-stimulating hormone （FSH） among the three groups（P > 0.05）. After treatment， there were no significant differences in endometrial thickness on the conversion day or the extent of increase among the three groups（P > 0.05）. The clinical pregnancy rates in Group A， Group B， and Group C were 56.1%， 51.6%， and 43.2% respectively， with a significant difference （P = 0.011）； the embryo implantation rates were 43.6%， 45.5%， and 34.6% respectively， showing a significant difference（P = 0.019）. The early abortion rate in Group A （3.64%） was significantly lower than that in Group C （15.79%）（P < 0.01）. In terms of treatment cost of endometrial preparation treatment， the cost in Group A （676.5 ± 494.5 Yuan） was significantly lower than that in Group B （2 401.2 ± 764.2 Yuan） and Group C （3 093.8 ± 758.3 Yuan） （P < 0.01）. Conclusion In FET cycles for patients with thin endometrium， the clinical outcomes of TAM，TAM + PRP and HRT + PRP are comparable， and TAM demonstrates advantages in terms of a lower early miscarrage rate and better cost-effectiveness， thus serving as an option for endometrial preparation in patients with thin endometrium.

Key words： thin endometrium; tamoxifen; platelet-rich plasma; hormone replacement therapy; intrauterine perfusion

Cite this article

Congshun MA , Yuanyuan CUI , Wanshan ZHU , Xuejun ZHAN , Ying TAN . Clinical outcomes of three treatment protocols for frozen⁃thawed embryo transfer in patients with thin endometrium[J]. The Journal of Practical Medicine, 2025 , 41(22) : 3474 -3479 . DOI: 10.3969/j.issn.1006-5725.2025.22.002

References

[1] HARRIS E. Infertility Affects 1 in 6 People Globally［J］. JAMA， 2023， 329（17）： 1443. doi:10.1001/jama.2023.6251
[2] LEE M C， CHIEN P S， ZHOU Y， et al. Prevalence and help-seeking for infertility in a population with a low fertility rate［J］. PLoS One， 2024， 19（7）： e306572. doi:10.1371/journal.pone.0306572
[3] REN R， ZHOU X， JIA T， et al. Developmental exposure to perfluorooctane sulfonate （PFOS） impairs the endometrial receptivity［J］. Sci Rep， 2025， 15（1）： 1747. doi:10.1038/s41598-024-84732-2
[4] ABOULGHAR M A， ABOULGHAR M M. Optimum endometrial thickness before embryo transfer： An ongoing debate［J］. Fertil Steril， 2023， 120（1）： 99-100. doi:10.1016/j.fertnstert.2023.04.013
[5] WANG Y， TANG Z， TENG X. New advances in the treatment of thin endometrium［J］. Front Endocrinol （Lausanne）， 2024， 15： 1269382. doi:10.3389/fendo.2024.1269382
[6] WANG Y， TANG Z， TENG X. New advances in the treatment of thin endometrium［J］. Front Endocrinol （Lausanne）， 2024， 15： 1269382. doi:10.3389/fendo.2024.1269382
[7] BU Z， HU L， YANG X， et al. Cumulative Live Birth Rate in Patients With Thin Endometrium： A Real-World Single-Center Experience［J］. Front Endocrinol （Lausanne）， 2020， 11： 469. doi:10.3389/fendo.2020.00469
[8] ZHENG Y， CHEN B， DAI J， et al. Thin endometrium is associated with higher risks of preterm birth and low birth weight after frozen single blastocyst transfer［J］. Front Endocrinol （Lausanne）， 2022， 13： 1040140. doi:10.3389/fendo.2022.1040140
[9] 周敏，张潇潇，吴钊. 阿司匹林对子宫内膜异位症合并薄型子宫内膜冻融胚胎移植的影响 ［J］. 实用医学杂志，2025， 41 （1）： 95-99.
[10] LI X， SU Y， XIE Q， et al. The Effect of Sildenafil Citrate on Poor Endometrium in Patients Undergoing Frozen-Thawed Embryo Transfer following Resection of Intrauterine Adhesions： A Retrospective Study［J］. Gynecol Obstet Invest， 2021， 86（3）： 307-314. doi:10.1159/000516749
[11] JI M， FU X， HUANG D， et al. Effect of tamoxifen in patients with thin endometrium who underwent frozen-thawed embryo transfer cycles： A retrospective study［J］. Front Endocrinol （Lausanne）， 2023， 14： 1195181. doi:10.3389/fendo.2023.1195181
[12] CAKIROGLU Y， TOHMA Y A， YUCETURK A， et al. A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer： A prospective cohort study［J］. BMC Pregnancy Childbirth， 2025， 25（1）： 297. doi:10.1186/s12884-025-07400-x
[13] KARADBHAJNE P， DZOAGBE H Y， MORE A. Platelet-Rich Plasma （PRP） for Endometrial Treatment Efficacy and Safety in Assisted Reproductive Technology： A Comprehensive Review［J］. Cureus， 2024， 16（5）： e59728.
[14] GURKAN N， ALPER T. The effect of endometrial PRP on fertility outcomes in women with implantation failure or thin endometrium［J］. Arch Gynecol Obstet， 2025， 311（4）： 1195-1204. doi:10.1007/s00404-025-07948-1
[15] KHAN M， MORE A， ANJANKAR N. The Comparative Study of Platelet Rich Plasma （PRP） and Plasma Rich in Growth factor （PRGF） in Endometrial Thickness， Implantation Rate and Pregnancy Outcomes in IVF Patients［J］. J Pharm Bioallied Sci， 2025， 17（）： S952-S955. doi:10.4103/jpbs.jpbs_409_25
[16] LIU X， QIAN C， JIANG X， et al. Efficacy of platelet-rich plasma in the treatment of thin endometrium： A meta-analysis of randomized controlled trials［J］. BMC Pregnancy Childbirth， 2024， 24（1）： 567. doi:10.1186/s12884-024-06741-3
[17] ZHANG H， HU X， WANG W， et al. Autologous Platelet-Rich Plasma Combined with Endometrial Microstimulation to Improve Thin Endometrium Status and Clinical Outcomes： A Prospective Controlled Study［J］. Ann Clin Lab Sci， 2025， 55（2）： 185-191.
[18] 胡琳莉，黄国宁，孙海翔，等. 辅助生殖技术临床关键指标质控专家共识 ［J］. 生殖医学杂志，2018， 27（9）： 828-835.
[19] BERGENHEIM S J， SAUPSTAD M， PISTOLJEVI? N， et al. Immediate versus postponed frozen embryo transfer after IVF/ICSI： A systematic review and meta-analysis［J］. Hum Reprod Update， 2021， 27（4）： 623-642. doi:10.1093/humupd/dmab002
[20] EFENDIEVA Z， VISHNYAKOVA P， APOLIKHINA I， et al. Hysteroscopic injections of autologous endometrial cells and platelet-rich plasma in patients with thin endometrium： A pilot randomized study［J］. Sci Rep， 2023， 13（1）： 945. doi:10.1038/s41598-023-27982-w
[21] CHEN R， WANG R， YU Y， et al. Intravaginal electrical stimulation for the treatment of pelvic floor dysfunction： A systematic review and meta-analysis［J］. Front Neurol， 2024， 15： 1378494. doi:10.3389/fneur.2024.1378494
[22] KE H， JIANG J， XIA M， et al. The Effect of Tamoxifen on Thin Endometrium in Patients Undergoing Frozen-Thawed Embryo Transfer［J］. Reprod Sci， 2018， 25（6）： 861-866. doi:10.1177/1933719117698580
[23] SHI Q， HUANG C， LIU J， et al. Hormone replacement therapy alone or in combination with tamoxifen in women with thin endometrium undergoing frozen-thawed embryo transfer： A retrospective study［J］. Front Endocrinol （Lausanne）， 2023， 14： 1102706. doi:10.3389/fendo.2023.1102706
[24] JI M， FU X， HUANG D， et al. Effect of tamoxifen in patients with thin endometrium who underwent frozen-thawed embryo transfer cycles： A retrospective study［J］. Front Endocrinol （Lausanne）， 2023， 14： 1195181. doi:10.3389/fendo.2023.1195181
[25] EBRAHIMI R， MAHMOUDINIA M， KHADEM N， et al. Comparison of tamoxifen and hormone replacement cycle （HRT） in frozen embryo transfer. A randomized controlled trial［J］. JBRA Assist Reprod， 2023， 27（2）： 241-246.
[26] KIM M K， SONG H， LYU S W， et al. Platelet-rich plasma treatment in patients with refractory thin endometrium and recurrent implantation failure： A comprehensive review［J］. Clin Exp Reprod Med， 2022， 49（3）： 168-174. doi:10.5653/cerm.2022.05407
[27] SUN L， YIN B， YAO Z， et al. Comparison of clinical outcomes and perinatal outcomes between natural cycle and hormone replacement therapy of frozen-thawed embryo transfer in patients with regular menstruation： A propensity score-matched analysis［J］. Front Endocrinol （Lausanne）， 2024， 15： 1416841. doi:10.3389/fendo.2024.1416841
[28] LI X， GAO Y， SHI J， et al. Natural cycle increases the live-birth rate compared with hormone replacement treatment for frozen-thawed single euploid blastocyst transfer［J］. Front Endocrinol （Lausanne）， 2022， 13： 969379. doi:10.3389/fendo.2022.969379
Options
Outlines

/

〈 〉